Skip to content

A study in healthy men to test how bosentan influences the amount of zongertinib in the blood

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523193-16-00
Enrollment
16
Registered
2026-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 16, 2026